The aims of this study were therefore to examine associations between genetic polymorphisms near the interferon-lambda genes, IFNL2, IFNL3, and IFNL4 and HCV RNA spontaneous clearance among patients in the community and to evaluate the effect of these polymorphisms on the risk for HCC. This evidence concerns the gene IFNL2 and hepatocellular carcinoma.